D-0745-2026 Class II Ongoing

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0745-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Aug 5, 2026 and is designated Class II. Reason for recall: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Aug 12, 2026
Initiation Date
Aug 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

Reason for recall

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Distribution pattern

Nationwide in the USA

Code information

Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0745-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0745-2026. Report a data issue: hello@regdatalab.com.